Dry AMD is a leading cause of vision loss among older Americans and as of this writing, has no treatment. In a potentially breakthrough study, the first U.S.-based AMD patient has been treated in the phase 1/2a clinical trial (NCT04339764) of an autologous induced pluripotent stem cell (iPSC) therapy for the treatment of dry age-related macular degeneration (AMD) by the NIH. … [Read more...] about NIH: First U.S. patient receives autologous stem cell therapy to treat dry AMD
Medical Conditions
Using Stem Cells for Amyotrophic Lateral Sclerosis (ALS) Patients
Advancements in stem cell research may one day help surgeons provide treatment for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig’s disease, a deadly neurodegenerative disease characterized by the selective death of motor neurons. CD133+ stem cells are known to have the capacity to differentiate into neural lineages and may provide an alternative treatment for … [Read more...] about Using Stem Cells for Amyotrophic Lateral Sclerosis (ALS) Patients